DVC is helping the U.S. and allied governments protect soldiers and civilians against emerging diseases and possible bioterror threats. Programs we've managed include:
U.S. Department of Defense (DoD) Chemical Medical Biological Systems-Joint Vaccine Acquisition Program (CBMS-JVAP)
Botulinum Bivalent Vaccine
Plague Vaccine
National Institute of Allergy and Infectious Diseases (NIAID)
Next-Generation Tularemia Vaccine
Tularemia (LVS) Vaccine
U.S. Department of Health and Human Services (HHS)
Influenza Vaccine - Seasonal
Influenza Vaccine - Pandemic
UK Ministry of Defence
Scope requirements for licensing plague vaccine in the European Union
Additional Experience
Anthrax Vaccine (rPA)
Botulinum Pentavalent Vaccine
Botulinum Polyclonal Antitoxin
Botulinum Type E Vaccine
Butyrylcholinesterase (BioScavenger)
Smallpox Vaccine (CCSV)
Vaccine Stockpile, Storage and Maintenance
Vaccinia Immune Globulin Intravenous (VIGIV)
Venezuelan Equine Encephalitis Vaccine
Related Links
DVC has been developing medical countermeasures for U.S. government agencies since 1997. Review our lessons learned.
Browse publications by DVC scientists and technical staff.